Aralia Racemosa

Generic Name: aralia racemosa

Over-the-Counter (OTC)

Brand Names:

Aralia Racemosa Mt

Batch no. 40021 Restest Date: 11/2022

Overview

Batch no. 40021 Restest Date: 11/2022

Uses

Batch no. 40021 Restest Date: 11/2022

Warnings

Caution: for manufacturing,processing or repacking only. Caution: for manufacturing, processing or repacking only.

Frequently Asked Questions

What is Aralia Racemosa used for?

Batch no. 40021 Restest Date: 11/2022

What are the important warnings for Aralia Racemosa?

Caution: for manufacturing,processing or repacking only. Caution: for manufacturing, processing or repacking only.

Related Medications

Borax, Natrum Muriaticum, Causticum, Elettaria Cardamomum, Plumbum Metallicum, Sepia, Lilium Tigrinum, Oxytropis Lambertii

borax, natrum muriaticum, causticum, elettaria cardamomum, plumbum metallicum, sepia, lilium tigrinum, oxytropis lambertii

PURPOSE: Aids in relief of anxiety.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Resmetirom

resmetirom

Thyroid Hormone Receptor beta Agonist [EPC]

11 DESCRIPTION REZDIFFRA (resmetirom) tablets contain resmetirom, a thyroid hormone receptor-beta agonist. The chemical name for REZDIFFRA is 2-[3,5-Dichloro-4-((6-oxo-5-(propan-2-yl)-1,6-dihydropyridazin-3-yl)oxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile. The molecular formula is C 17 H 12 Cl 2 N 6 O 4 and the molecular weight is 435.22. The chemical structure is: Resmetirom has low aqueous solubility below pH 6 and higher solubility above pH 7 (0.44 mg/mL at pH 7.04).

Perflutren

perflutren

Contrast Agent for Ultrasound Imaging [EPC]

11 DESCRIPTION DEFINITY RT (perflutren lipid microsphere) injectable suspension is, after activation, an ultrasound contrast agent for intravenous use. The perflutren lipid microspheres are composed of perflutren encapsulated in an outer lipid shell consisting of (R) – hexadecanoic acid, 1-[(phosphonoxy)methyl]-1,2-ethanediyl ester, monosodium salt (abbreviated DPPA); (R) - 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]-3,4,9-trioxa-4-phosphapentacosan-1-aminium, 4-oxide, inner salt (a

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.